The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 11/Signature 1
From BugSigDB
< The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies | The Gut Microbiome in Parkinson's Disease: A Longitudinal Study of the Impacts on Disease Progression and the Use of Device-Assisted Therapies/Experiment 11
Needs review
Source: Figure 2B
Description: Volcano plots representing abundance differences (fold change) of different taxa between HC and PD patients at t = 0, t = 6, and t = 12 months. Statistically significant [–log(p) > 3; fold change > ± 1.3] compositional differences at the genus and family levels (represented by red dots) were apparent and indicative of a PD-related GM composition. Genus taxonomic level, at the t = 0
Abundance in Group 1: decreased abundance in Parkinson's disease (PD) patients at (t=0)
| NCBI | Quality Control | Links |
|---|---|---|
| Butyricicoccus | ||
| Firmicutes bacterium CAG:56 | ||
| Fusicatenibacter | ||
| lachnospiraceae ND3007 grouplachnospiraceae ND3007 group | ||
| Erysipelotrichaceae UCG 003Erysipelotrichaceae UCG 003 |
Revision editor(s): Fiddyhamma
